NCT05693311 is a clinical trial in IBD, sponsored by Youstina Yosry Soliman.

Who is sponsoring NCT05693311?

NCT05693311 is sponsored by Youstina Yosry Soliman.

What condition does NCT05693311 study?

NCT05693311 studies IBD, Joint Diseases.

Is NCT05693311 still recruiting?

NCT05693311 is currently status unknown. Last updated 20 January 2023.

Last reviewed 2023-01-20 · How we verify

NCT05693311

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inflammatory Bowel Disease Related Joint Manifestations

Status unknown Last updated 20 January 2023

What this trial tests

trial in IBD in 217 participants. Status unknown.

Timeline

1 March 2023

Primary endpoint
31 December 2024

1 March 2025

Quick facts

Lead sponsor	Youstina Yosry Soliman
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	217
Start date	1 March 2023
Primary completion	31 December 2024
Estimated completion	1 March 2025

Conditions studied

IBD — all drugs for IBD →
Joint Diseases — all drugs for Joint Diseases →

Sponsor

Youstina Yosry Soliman

Who can join

Adults 18 to 90, any sex, with IBD or Joint Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this research is to identify incidence of jiunt manifestations by its both types axial and periphral in IBD patients, its types , relation to IBD activity, lines of treatment using and how they are effective in prevention and in treatment of these joint manifestations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for IBD

Currently open trials in the same condition.

NCT07385807 — Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Out · recruiting
NCT07271264 — A Randomised Paired Design Study of Texture and Colour Enhancement Imaging (TXI) Versus High-definition White Light Endo · NA · recruiting
NCT07224113 — Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD · recruiting
NCT07195123 — Evaluation of the SMART IBD App in Pediatric IBD · NA · recruiting
NCT07380022 — Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Def · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05693311 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Youstina Yosry Soliman
Last refreshed: 20 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05693311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing